Trial intelligence / Profile preview

Dexmedetomidine in awake implantation of neuromodulative systems

2014-001587-35Phase 2Completed

Sponsor
Erasmus MC
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of dexmedetomidine in procedural pain and Procedural anxiety, sponsored by Erasmus MC. Primary endpoint: Patient overall satisfaction. Started Jul 2014; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

procedural painProcedural anxiety

Beyond the preview

Go deeper on 2014-001587-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-001587-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call